Obermatt
See Similar Stocks →

DSM-Firmenich

AEX:DSFIR · CH1216478797
ChemicalsX-Large

360

23
EV / EBIT42
Price / Owner Earnings93
Owner Earnings Yield1
Dividend Yield75
Price/Sales27
EV / Gross Profit62
Price/Book72
Return on Capital3
Cash Return on Capital12
Return on Equity23
EBIT Margin15
Gross Profitability17
Accruals89
Owner Earnings Margin6
Sales growth4
Profit Growth83
Long-Term EPS Growth57
Owner Earnings Growth1
Reinvestment18
Price momentum9
Debt load79
Refinancing52
Debt Payback1
Liquidity41
Analyst ratings59
Opinion Changes50
Price Target Upside46
Market mood73
Value Creation2/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

DSM-Firmenich doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountrySwitzerland
IndustryChemicals
SizeX-Large
TypePublic Company
ExchangeENXTAM
Employees11,059
Websitedsm-firmenich.com
ISINCH1216478797
Last UpdateApr 2, 2026
Indices
AEX (Netherlands)
Themes
Alternative ProteinOrganicAnimal FeedLifestyleNutraceuticalBeautyChemicalHealth CareManufacturingNutrition

Description

DSM-Firmenich AG is a global leader in nutrition, health, and sustainable living. The company integrates science with business, leveraging biodegradable raw materials, sophisticated production processes, and innovative technologies to provide product…

Analysis

Weak and unloved

DSM-Firmenich AG scores below average on quality and is priced accordingly, a low-conviction position in either direction.

Valuation data is not available for this company.

Growth is weak; the safety picture is adequate. The company scores 2/20 on our value-creation score: not creating value. Analysts lean positive.

Flags to be aware of: Some accounting patterns deserve a closer look. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
41
2026

All-time high

45

Feb 2026

All-time low

23

Mar 2026

Average rank

36

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
27
—
—
—
Price/Earnings
27
—
—
—
Price/Book
72
—
—
—
Dividend Yield
75
—
—
—
Value (overall)
50
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare DSM-Firmenich with its peers
Symrise
GER:SY1
27
CountryGermany
IndustryChemicals
SizeLarge
Full Stock Analysis →
BRAIN Biotech
GER:BNN
40
CountryGermany
IndustryChemicals
SizeSmall
Full Stock Analysis →
Novozymes
CPH:NSIS B
45
CountryDenmark
IndustryChemicals
SizeX-Large
Full Stock Analysis →
Sol
MIL:SOL
50
CountryNetherlands
IndustryChemicals
SizeLarge
Full Stock Analysis →
BASF
GER:BAS
38
CountryGermany
IndustryChemicals
SizeXX-Large
Full Stock Analysis →
Fermentalg
PAR:ALGAE
39
CountryFrance
IndustryChemicals
SizeX-Small
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →